Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

6.20
Delayed Data
As of Sep 28
 +0.05 / +0.81%
Today’s Change
4.39
Today|||52-Week Range
10.85
-21.52%
Year-to-Date
Bullish and Bearish Reversals for the Week
Sep 26 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close6.15
Today’s open6.20
Day’s range6.05 - 6.30
Volume3,022,563
Average volume (3 months)2,139,196
Market cap$794.8M
Dividend yield--
Data as of 09/28/2016

Growth & Valuation

Earnings growth (last year)-66.25%
Earnings growth (this year)+18.14%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)-13.14%
P/E ratioNM
Price/Sales9.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
GBTGlobal Blood Therape...-0.19-0.86%
RPTPRaptor Pharmaceutica...+0.01+0.11%
TBRATobira Therapeutics ...0.000.00%
VNDAVanda Pharmaceutical...-0.13-0.77%
Data as of 09/28/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$89.3M
Annual profit (last year)-$148.0M
Net profit margin-165.76%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Search for Jobs